The Journal of Antibiotics
Online ISSN : 1881-1469
Print ISSN : 0021-8820
ISSN-L : 0021-8820
Volume 29, Issue 4
Displaying 1-21 of 21 articles from this issue
  • KENNETH L. Jr. RINEHART, RONALD M. STROSHANE
    1976 Volume 29 Issue 4 Pages 319-353
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Download PDF (16438K)
  • TAXONOMY, FERMENTATION, ISOLATION AND CHARACTERIZATION
    MASAYUKI OHSHIMA, NOBORU ISHIZAKI, KIMIHIKO ABE, MASUFUMI UKAWA, YASUM ...
    1976 Volume 29 Issue 4 Pages 354-365
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Antibiotic DE-3936 was isolated from the fermentation broth of a streptomycete No. 9735-1, which is identified as a strain of Streptomyces hygroscopicus. The antibiotic is a hydrophobic compound having the molecular formula of C44H75O14Na and is active against Gram-positive bacteria, mycobacteria, mycoplasma and protozoa. especially coccidia. Its chemical and biological properties indicate that antibiotic DE-3936 belongs to the group of polyether antibiotics and is identical with lonomycin.
    Download PDF (5664K)
  • STUDIES ON ANTIBIOTICS FROM THE GENUS BACILLUS. VIII
    JUN'ICHI SHOJI, HIROSHI HINOO, YOSHIHARU WAKISAKA, KENZO KOIZUMI, MIKA ...
    1976 Volume 29 Issue 4 Pages 366-374
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Thiocillins I and It were isolated from the culture broth of Bacillus cereus G-15, and thiocillins II and III from that of Bacillus badius AR-91. Also, the former two were probably produced by Bacillus megatherium I-13. These antibiotics active against Gram-positive bacteria are soluble in a mixture of chloroform and methanol, show characteristic ultraviolet absorptions (maxima at ca. 275 nm and ca. 348 nm), and contain a high content of sulfur, as much as approximately 15%. They are related to each other and also to micrococcin P, but differentiated by chromatographic behaviours.
    Download PDF (4858K)
  • STUDIES ON ANTIBIOTICS FROM THE GENUS BACILLUS. IX
    JUN'ICHI SHOJI, RYUZI SAKAZAKI, YOSHIHARU WAKISAKA, KENZO KOIZUMI, MIK ...
    1976 Volume 29 Issue 4 Pages 375-379
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    A new peptide antibiotic, brevistin, was isolated from the culture broth of Bacillus brevis 342-14. Brevistin is an acylpeptide with an approximate empirical formula of C63H91N15O18 containing aspartic acid, threonine, glycine, valine, isoleucine, phenylalanine, tryptophan and 2, 4-diaminobutyric acid. The antibiotic is soluble in acid and alkaline water. Its hydrochloride is soluble in methanol. Brevistin is active against Ggam-positive bacteria in vitro and in vivo, and is of low toxicity to mice.
    Download PDF (2313K)
  • STUDIES ON ANTIBIOTICS FROM THE GENUS BACILLUS. X
    JUN'ICHI SHOJI, TOSHIYUKI KATO
    1976 Volume 29 Issue 4 Pages 380-389
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Acid hydrolysis revealed the constituent amino acids of brevistin as follows: aspartic acid (D-form 2, L-form 1), L-threonine (1), glycine (1), sum of L-valine and L-isoleucine (1), [L-phenylalanine (1), L-tryptophan (1), and 2, 4-diaminobutyric acid (D-form 1, L-form 1). The constituent fatty acid was elucidated to be anteisononanoic acid by gas chromatography-mass spectrometry. A lactone linkage was proved between phenylalanine and the hydroxy group of threonine. Opening the lactone ring with dilute alkali afforded brevistinic acid. Deacylation with an enzyme preparation, Polymyxin Acylase, gave deacyl brevistinic acid. Cleavage reaction with N-bromosuccinimide, sequential analysis by EDMAN degradation and some additional evidences clarified the total structure of brevistin.
    Download PDF (5505K)
  • STUDIES ON ANTIBIOTICS FROM THE GENUS BACILLUS. XIII
    JUN'ICHI SHOJI, RYUZI SAKAZAKI, YOSHIHARU WAKISAKA, KENZO KOIZUMI, MIK ...
    1976 Volume 29 Issue 4 Pages 390-393
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    A new antibiotic, named laterosporamine, was isolated from the culture broth of Bacillus laterosporus 340-19. The antibiotic is active against Gram-positive and Gram-negative bacteria in vitro and in vivo. It is a water-soluble basic substance, positive to ninhydrin, SAKAGUCHI's and DRAGENDORFF's reagents. A non-peptidic structure with an approximate empirical formula C17H35N7O4 was suggested.
    Download PDF (2029K)
  • D. H. BERG, R. P. MASSING, M. M. HOEHN, L. D. BOECK, R. L. HAMILL
    1976 Volume 29 Issue 4 Pages 394-397
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    A new antibiotic, designated A30641, having in vitro activity against Gram-positive bacteria and fungi has been isolated from a strain of Aspergillus tamarii. Chemical and physical characterization indicate that it is a member of the class of antibiotics containing the epidithiodiketopiperazine moiety.
    Download PDF (1744K)
  • TADASHI ARAI, KATSUKIYO YAZAWA, YUZURU MIKAMI, AKINORI KUBO, KATSUHIRO ...
    1976 Volume 29 Issue 4 Pages 398-407
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Under novel conditions of culture, Streptomyces lavendulae No. 314 was found to produce new antibiotics, chlorocarcins and mimosamycin in addition to streptothricin. The antibiotics are extracted from culture filtrate with organic solvents and further purified by silica gel chromatography. Chlorocarcins A, B, and C are closely related basic antibiotics which are active against gram-positive bacteria, EHRLICH carcinoma and L 1210 leukemia of mice. Mimosamycin is a neutral antibiotic which is mainly active against mycobacteria. Production, isolation and physicochemical properties of the antibiotics are described.
    Download PDF (4340K)
  • YUZURU MIKAMI, KOJI YOKOYAMA, AKIRA ÔMI, TADASHI ARAI
    1976 Volume 29 Issue 4 Pages 408-414
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    A strain of Streptomyces, No. 314 identified as a Streptomyces lavendulae produced under a novel condition of culture, four new antibiotics, mimosamycin and chlorocarcins A, B, and C. Among the components of chlorocarcin complex, chlorocarcin A was found to be most biologically active. This antibiotic inhibited the growth of Staphylococcus aureus FDA 209P and Corynebacterium diphtheriae at the concentrations of 0.1 and 0.003 mcg/ml, respectively. Chlorocarcin A also exhibited antitumor activity on EHRLICH carcinoma, ascitic and solid forms, and mouse leukemia L1210. Mimosamycin proved to be mainly active on Mycobacterium tuberculosis and inactive on the experimental murine tumors.
    Download PDF (3515K)
  • TOSHIAKI YAMASHITA, NORIYUKI NAOI, KIYOSHI WATANABE, TOMIO TAKEUCHI, H ...
    1976 Volume 29 Issue 4 Pages 415-423
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    The antitumor polypeptide, macromomycin (MCR) produced by Streptomyces macromomyceticus, was purified by ammonium sulfate precipitation, ultrafiltration and chromatographic techniques using Amberlite IRA-410, DEAE Sephadex A-25 (Cl- and OH- type) and Sephadex G-50. Purified MCR was obtained as a white powder by lyophilization. MCR, thus purified, exhibited a single peak on Sephadex G-50 chromatography
    with no detectable contaminant by ultracentrifugation and polyacrylamide gel electrophoresis. MCR is an acidic polypeptide having an isoelectric point of pH 5.4. It contains no arginine and methionine. The molecular weight was 11, 700, 12, 500 and 11, 400 by amino acid composition, gel filtration and analytical ultracentrifugation, respectively. MCR is labile as a lyophilized powder but is successfully stabilized by the addition of maltose.
    Download PDF (4419K)
  • MICHAEL O. CHANEY, NOEL D. JONES, MANUEL DEBONO
    1976 Volume 29 Issue 4 Pages 424-427
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    The crystal and molecular structures of the calcium complex of A23187 has been determined by X-ray diffraction studies.
    Download PDF (1630K)
  • FURTHER CHARACTERIZATION AND C-TERMINAL STRUCTURE OF ACTINOCARCIN
    TSUYOSHI KIHARA, SABURO SUZUKI, HIROSHI YONEHARA
    1976 Volume 29 Issue 4 Pages 428-432
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    The amino-acid composition and molecular weight of actinocarcin, and C-terminal structure of actinocarcin are reported in this paper. By STEIN-MOORE'S and ultraviolet-absorption methods, the molar ratio of amino acids in actinocarcin was determined. The N-terminal amino acids are alanine and valine. The C-terminal amino acid, determined by hydrazinolysis, is tryptophan. The molecular weight is about 11, 000 as estimated by ARCHIBALD'S method and amino acid analysis. Three fragments, named BrCN-I, BrCN-II and BrCN-III, were obtained by cyanogen bromide cleavage. The structure of BrCN-III, namely the C-terminal structure of actinocarcin was determined by EDMAN degradation
    Download PDF (2304K)
  • B. MEESSCHAERT, P. ADRIAENS, H. EYSSEN, E. ROETS, H. VANDERHAEGHE
    1976 Volume 29 Issue 4 Pages 433-437
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    The synthesis of benzylpenicillin and 6-aminopenicillanic acid, labeled with tritium in the β-methyl group, is described. Benzylpenicillin S-sulfoxide benzyl ester is refluxed in benzene and tritiated water and is successively debenzylated and deoxygenated to (β-methyl-3H)-benzylpenicillin. Removal of the side chain with a bacterial acylase gives (β-methyl-3H)-6-aminopenicillanic acid.
    Download PDF (2367K)
  • NOBUO MONJI, WITOLD MECHLINSKI, CARL P. SCHAFFNER
    1976 Volume 29 Issue 4 Pages 438-443
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Amphotericin B-3H with a specific radioactivity in excess of 4 μCi/mg was produced by fermentation of Streptomyces nodosus IMRU 3694 in a complex medium, using acetate-3H as a precursor. The medium employed gave a production yield of 2.5-3.5 mg/ml of amphotericin B. The most efficient incorporation of acetate-3H occurred when the precursor was added at 24 hours after inoculation. It was observed, that the amount of amphotericin A co-produced in the fermentation broth with amphotericin B was significantly reduced by the addition of ethanol to the production medium. Complete inhibition of amphotericin A production was achieved at a level of 2% ethanol in the fermentation medium without an appreciable effect on the yield of amphotericin B. Methanol, 1-propanol, 2-propanol and 1-butanol lowered the yield of both antibiotics indiscriminately. The syntheses of amphotericin B-3H-Na desoxycholate (carboxyl-14C) complex and amphotericin B-3H methyl 14C-ester are also described.
    Download PDF (2964K)
  • MINORU NISHIDA, TAKEO MURAKAWA, TOSHIAKI KAMIMURA, NAOHIKO OKADA, HIRO ...
    1976 Volume 29 Issue 4 Pages 444-459
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    FR10612, like cephalexin, is a broad-spectrum oral cephalosporin derivative. The antimicrobial activity of FR10612 against clinical isolates was similar to cephalexin; however, at a low inoculum size its activity was greater than cephalexin against Klebsiella pneumonia and Proteus mirabilis strains. Like cephalexin, the in vitro bactericidal activity of FR10612 was more influenced by the duration of contact with the test organism than by drug concentration. The bactericidal activity of FR10612 against E. coli 317 was greater than that of cephalexin in an in vitro model system which simulated the serum levels of FR10612 and cephalexin achieved in healthy volunteers after a single oral dose. The protein binding of FR10612 to human and animal serum was extremely low. FR10612 was resistant to β-lactamases from gram-negative bacilli. It showed resistance similar to cephalexin, but was more resistant to β-lactamases than were cephaloridine, cephalothin and cefazolin. The protective effect of FR10612 in mice infected with various pathogens was greater than cephalexin. The serum levels of FR10612 in rats were higher and more prolonged than those of cephalexin. Tissue levels of FR10612 in rats also persisted for a long time period reflecting the serum levels. In healthy volunteers, rabbits and monkeys the serum levels of FR10612 were initially lower than those of cephalexin but persisted for a longer time period. The total 24-hour urinary excretion of FR10612 in healthy volunteers after oral administration was almost the same as that of cephalexin, but the excretion rate of FR10612 was slower, and the urinary levels were more persistent than those of cephalexin.
    Download PDF (7068K)
  • J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE, G. H. WARREN
    1976 Volume 29 Issue 4 Pages 460-465
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    The therapeutic properties of nafcillin, oxacillin and erythromycin were determined in mice infected with a strain (Evans) of Staphylococcus aureus shown to be tolerant to the bactericidal action of penicillinase-resistant derivatives of penicillin. The therapeutic activity of these agents was also correlated with the extent of colonization of kidneys by resistant clones of S. aureus Evans. The CD50 values or potency ratios proved that nafcillin was highly active against this organism, whereas oxacillin and erythromycin were capable of protecting the animals to a lesser degree . Of the agents studied, only nafcillin was capable of preventing or interfering with the colonization of the kidneys by S. aureus Evans. Although the exact interpretation and application of these data in the management of clinical problems remains to be determined, the observations suggest important differences between nafcillin and oxacillin in vivo and that it is difficult to predict the antibacterial efficacy of these drugs solely from MIC and MBC data.
    Download PDF (3116K)
  • GIANCARLO LANCINI, GIUSEPPE SARTORI
    1976 Volume 29 Issue 4 Pages 466-468
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Download PDF (1566K)
  • M. G. BRAZHNIKOVA, V. B. ZBARSKY, D. TRESSELT, K. ECKARDT
    1976 Volume 29 Issue 4 Pages 469-471
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Download PDF (1064K)
  • VINCE POZSGAY, JÓZSEF TAMÁS, GÁBOR CZIRA, TONI WI ...
    1976 Volume 29 Issue 4 Pages 472-476
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Download PDF (2013K)
  • SATOSHI OMURA, TAKAAKI NISHIKIORI, RUIKO OIWA, YUZURU IWAI, ROKUROU MA ...
    1976 Volume 29 Issue 4 Pages 477-478
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Download PDF (904K)
  • YASUHIRO SUMINO, SHUN-ICHI AKIYAMA, KONOMI HAIBARA, MITSUKO ASAI, KOME ...
    1976 Volume 29 Issue 4 Pages 479-482
    Published: 1976
    Released on J-STAGE: April 12, 2006
    JOURNAL FREE ACCESS
    Download PDF (1865K)
feedback
Top